Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q1

4544.TEDINET S100RLNC
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥56.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥260.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥65.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income−¥1.7bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥8.6bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income−¥1.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥22.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥8.5bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥1.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥8.1bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥1.1bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.6bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥1.1bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥5.6bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥289.6bnat 2023-06-30Cons.Assets
Total assets¥297.9bnat 2023-03-31Cons.Assets
Total assets¥278.3bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥139.8bnat 2023-06-30Cons.Liabilities
Total liabilities¥147.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥149.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥150.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥146.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥32.7bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥44.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥32.7bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥44.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥39.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥6.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥6.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.0bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥29.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥7.3bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.7bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-19.672023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥275.522022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥98.252022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥275.52022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥98.242022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio51.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio50.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio52.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥1.4bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥1.4bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥1.6bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥36.1bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥36.1bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥18m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2023-04-01 → 2023-06-30−¥2.8bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥14.7bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥13.4bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.3bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1m
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2023-04-01 → 2023-06-30¥355m
—segment totalrevenue2023-04-01 → 2023-06-30¥58.0bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥56.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥1.4bn
—segment totalsegment profit2023-04-01 → 2023-06-30−¥121m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥3.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥3.5bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥607m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥43.4bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥43.4bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥27m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥15.0bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥4m
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-06-30¥440m
—segment totalrevenue2022-04-01 → 2022-06-30¥68.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥65.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥3.5bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥9.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 459
ItemContextValueUnit
Intangible assetsPrior1YearInstant45373000000JPY
Intangible assetsCurrentQuarterInstant45558000000JPY
Investment securitiesPrior1YearInstant6997000000JPY
Investment securitiesCurrentQuarterInstant7232000000JPY
Other ioaPrior1YearInstant33558000000JPY
Other ioaCurrentQuarterInstant35391000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-165000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-431000000JPY
Investments and other assetsPrior1YearInstant40390000000JPY
Investments and other assetsCurrentQuarterInstant42191000000JPY
Noncurrent assetsPrior1YearInstant165977000000JPY
Noncurrent assetsCurrentQuarterInstant168256000000JPY
Deferred assetsPrior1YearInstant95000000JPY
Deferred assetsCurrentQuarterInstant89000000JPY
AssetsPrior1YearInstant297924000000JPY
AssetsCurrentQuarterInstant289590000000JPY
Notes and accounts payable tradePrior1YearInstant20512000000JPY
Notes and accounts payable tradeCurrentQuarterInstant19302000000JPY
Electronically recorded obligations operating clPrior1YearInstant1800000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant1313000000JPY
Short term loans payablePrior1YearInstant－JPY
Short term loans payableCurrentQuarterInstant3500000000JPY
Current portion of long term loans payablePrior1YearInstant3700000000JPY
Current portion of long term loans payableCurrentQuarterInstant－JPY
Accounts payable otherPrior1YearInstant12368000000JPY
Accounts payable otherCurrentQuarterInstant12318000000JPY
Income taxes payablePrior1YearInstant1782000000JPY
Income taxes payableCurrentQuarterInstant929000000JPY
Provision for bonusesPrior1YearInstant6256000000JPY
Provision for bonusesCurrentQuarterInstant2488000000JPY
Other clPrior1YearInstant17950000000JPY
Other clCurrentQuarterInstant13156000000JPY
Current liabilitiesPrior1YearInstant64371000000JPY
Current liabilitiesCurrentQuarterInstant53008000000JPY
Bonds payablePrior1YearInstant35000000000JPY
Bonds payableCurrentQuarterInstant35000000000JPY
Long term loans payablePrior1YearInstant25000000000JPY
Long term loans payableCurrentQuarterInstant27800000000JPY
Net defined benefit liabilityPrior1YearInstant6609000000JPY
Net defined benefit liabilityCurrentQuarterInstant6710000000JPY
Asset retirement obligations nclPrior1YearInstant1576000000JPY
Asset retirement obligations nclCurrentQuarterInstant1584000000JPY
Provision for share based remuneration nclPrior1YearInstant743000000JPY
Provision for share based remuneration nclCurrentQuarterInstant791000000JPY
Provision for compensation loss nclPrior1YearInstant562000000JPY
Provision for compensation loss nclCurrentQuarterInstant610000000JPY
Provision for loss on guaranteesPrior1YearInstant264000000JPY
Provision for loss on guaranteesCurrentQuarterInstant155000000JPY
Other nclPrior1YearInstant13750000000JPY
Other nclCurrentQuarterInstant14141000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass